Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial.
P. Dandona, C. Mathieu, M. Phillip, L. Hansen +163 more
Researcher profile · Semantic Scholar
P. Dandona, C. Mathieu, M. Phillip, L. Hansen +163 more
F. Pasquel, Georgia M. Davis, David M. Huffman, A. Peters +24 more
A. Bhargava, R. Bergenstal, Mark L. Warren, James R. Thrasher +11 more
Mark L. Warren, R. Bergenstal, Matthew Hager, E. Bashan +1 more
F. Pasquel, Georgia M. Davis, David M. Huffman, Anne L. Peters +24 more
A. Bhargava, James R. Thrasher, Bruce W. Bode, Mark L. Warren +11 more
H. Akturk, Laura M. Nally, Rayhan A. Lal, Mark L. Warren +16 more
H. Akturk, John H. Reed, James R. Thrasher, Alexander Abitbol +9 more
Mark L. Warren, R. Bergenstal, Matthew Hager, E. Bashan +1 more